Literature DB >> 28535631

[A multi-center study for the association between the perception and control of disease among asthmatic patients in Chinese urban areas].

Y Nong1, J T Lin, W Q Wang, X Zhou, C Z Wang, M Huang, S X Cai, P Chen, Q C Lin, J Y Zhou, Y H Gu, Y D Yuan, D J Sun, X H Yang, L Yang, J M Huo, Z C Chen, P Jiang, J Zhang, X W Ye, H G Liu, H P Tang, R Y Liu, C T Liu, W Zhang, C P Hu, Y Q Chen, X J Liu, L M Dai, W Zhou, Y J Huang, J Y Xu.   

Abstract

Objective: To investigate the current perception of disease among asthmatic patients in Chinese urban areas, and to address its association with asthma control.
Methods: This was a nationwide, multi-center, cross-sectional study covering 30 third-level, grade A hospitals in 30 provinces, municipalities and autonomous regions (not including Tibet) across Chinese mainland. The survey was carried out from October 2015 to May 2016. Asthmatic outpatients were selected to receive face-to-face questionnaire survey on asthma control including Asthma Control Test (ACT) score, classification of asthma control level[according to the Global Initiative for Asthma (GINA) 2015 classification system, as assessed by the physician completing the survey], perception of asthma (including question 1: nature of asthma as a disease; question 2: selection of first-line therapeutic agents to be regularly used daily for asthma; question 3: appropriate timing of the use of short-acting aerosols of β(2) receptor agonists; and question 4: therapeutic goals for asthma).
Results: A total of 3 875 asthmatic outpatients were included; among them, 69.0% (2 660/3 857) were aware that asthma is "an airway inflammatory disorder resulting from the combined effects of heredity and environment" ; 60.2% (2 321/3 857) considered "inhaled glucocorticoids or their compound preparations" to be the first-line therapeutic agents to be regularly used daily for patients with persistent chronic asthma; 85.7% (3 277/3 823) considered it appropriate to use short-acting aerosols of β(2) receptor agonists "as needed in the event of disease aggravation or acute exacerbation" ; and 75.4% (2 761/3 661) were aware that asthma "can be adequately or completely controlled in the long term" . The ACT score[20 (16, 23) vs 19 (16, 22) points; Z=-3.928, P<0.001]and asthma control rate (29.92% vs 25.31%; χ(2)=8.616, P=0.003) were significantly higher, and the rate of uncontrolled asthma (19.92% vs 23.48%; χ(2)=6.267, P=0.012) was significantly lower among the 2 660 (69.0%) patients correctly answering question 1 than among the 1 197 (31.0%) patients giving incorrect answer. The ACT score[21 (17, 23) vs 19 (15, 22) points; Z=-9.190, P<0.001] and asthma control rate (32.66% vs 22.20%; χ(2)=49.614, P<0.001) were significantly higher, and the rate of uncontrolled asthma (18.40% vs 25.00%; χ(2)=24.267, P<0.001) was significantly lower among the 2 321 (60.2%) patient correctly answering question 2 than among the 1 536 (39.8%) patients giving incorrect answer. Conclusions: Compared to previous surveys, there has been improved perception of disease among asthmatic patients in Chinese urban areas. Correct perception of disease is favorable for improving asthma control level.

Entities:  

Keywords:  Asthma; Cross-sectional study; Disease control; Disease perception; Questionnaires

Mesh:

Substances:

Year:  2017        PMID: 28535631     DOI: 10.3760/cma.j.issn.0376-2491.2017.18.015

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  Translation and validation of the Chinese version of Patient-completed Asthma Knowledge Questionnaire and its implementation in patient education.

Authors:  Bo Peng; Lin Sun; Yan Shang; Yajuan Zhang; Xiwen Gao; Ling Ye; Meiling Jin; Wei He; Zhijun Jie; Chunling Du; Lei Zhou; Yang Liu; Xiaolian Song; Juan Du; Fengying Zhang; Yi Gong; Yuheng Shi; Wuping Bao; Haihua Chen; Jin Wang; Chijun Wen; Weihao Li; Dandan Zhao; Gang Wang; Xin Zhou; Wei Tang
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

2.  Asthma Management Using the Mobile Asthma Evaluation and Management System in China.

Authors:  Jiangtao Lin; Wenya Wang; Huaping Tang; Jianmin Huo; Yuhai Gu; Rongyu Liu; Ping Chen; Yadong Yuan; Xiaohong Yang; Jianying Xu; Dejun Sun; Najia Li; Shujuan Jiang; Yiqiang Chen; Changzheng Wang; Lan Yang; Xiaoju Liu; Dong Yang; Wei Zhang; Zhuochang Chen; Qichang Lin; Chuntao Liu; Jianying Zhou; Xin Zhou; Chengping Hu; Ping Jiang; Wei Zhou; Jie Zhang; Shaoxi Cai; Chen Qiu; Mao Huang; Yijiang Huang; Huiguo Liu
Journal:  Allergy Asthma Immunol Res       Date:  2022-01       Impact factor: 5.764

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.